Strategy Could Expand Stem Cell Donor for People With Blood

A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive stem cells from unrelated, partially matched donors.

Related Keywords

Miami , Florida , United States , Jimenez , Antonio Jimenez , University Of Miami Miller School Medicine , National Marrow Donor Program , National Institutes Of Health , Healthday News , Miami Miller School , National Institutes , American Society , Clinical Oncology ,